National Science Foundation research by USF Health’s Larry Dishaw has relevance for debilitating digestive disorders like inflammatory bowel disease

What can we learn about human health from the lowly sea squirt?

More than you may think.

In his laboratory at the USF Children’s Research Institute in St. Petersburg, microbiologist Larry Dishaw, PhD, uses the sea squirt known as Ciona intestinalis to study how the innate immune system interacts with microbes that settle in the gut in ways that seem to facilitate homeostasis (stability) and promote survival and health.

Supported by a four-year, $867,581 grant from the National Science Foundation (NSF), Dr. Dishaw’s immune research explores the populations of microbes living together in the gut – trillions of bacteria, viruses, fungi and even some parasites – collectively known as the gut microbiome. His team is also interested in defining how disruption of a stable gut microbiome relates to the onset of inflammatory bowel disease, an autoimmune disorder affecting 1.6 million Americans.

Microbiologist Larry Dishaw, PhD, associate professor of pediatrics at the USF Health Morsani College of Medicine

“Many factors are at play in regulating the microbiome,” said Dr. Dishaw, an associate professor of pediatrics at USF Health Morsani College of Medicine. “And a lot of researchers around the world are interested in how the microbiome colonizes in animals, how this microbial community achieves stability, how it can shift out of balance, and how it is relevant to protecting human health.”

One of closest evolutionary invertebrate relatives of humans

Ciona intestinalis, an invertebrate marine animal resembling a spongy plant, spends its life attached to underwater structures like boat hulls and pier pilings where it continually siphons in water through one end, filtering out plankton and algae to eat and then squirting water and waste out the other end.

If you look under the microscope at the translucent juvenile sea squirts cultivated by Dr. Dishaw’s lab you can see a gut (with a stomach and intestinal compartment) similar to the digestive tract of vertebrates.  Despite its primitive appearance, the sea creature – a protochordate — is considered one of the closest evolutionary invertebrate relatives of humans.

Unlike humans, sea squirts rely their entire lives solely on naturally present innate immunity for host defense. They lack the other more evolved arm of immunity know as adaptive immunity, which differs from one animal species to the next and activates in response to specific foreign invaders.

The adult sea squirt Ciona intestinalis

That, Dr. Dishaw says, is what helps make the sea creature a good model for investigating the evolution of the host immune system and its role in creating and maintaining a well-balanced gut microbiome.

“When humans are born, they do not develop adaptive immunity until ages 3 to 5… so the initial process of colonizing bacteria and other microbes that make up their microbiomes is all mediated by innate immunity,” he said.

With a simpler model system like the sea squirt, the researchers can look at innate immunity in isolation. They can monitor how the immune system responds when encountering microbes for the first time, how microbes initially “choose” where to colonize in the gut, and how the animal maintains homeostasis – that is, a healthy balance of gut microbes needed to digest food and absorb nutrients throughout its life.

Ultimately, the not-so-lowly sea squirt may provide better insight into gut defense evolution and define ways that beneficial (non-pathogenic) bacteria may help prevent the overgrowth of disease-causing (pathogenic) bacteria.

Tipping the “good” microbe – “bad” microbe balance

Dr. Dishaw’s NSF grant builds upon the work of his mentor Gary Litman, PhD, USF professor emeritus of pediatrics, whose lab discovered the genes for a family of variable region-containing chitin-binding proteins, or VCBPs, made and secreted by the gut wall in a different protochordate, the ancient fish-like organism amphioxus. These immune proteins appear to help regulate how bacteria and fungi interact and grow such that intestinal barrier function is enhanced, Dr. Dishaw said. The VCBPs also seem to influence the production or release of phages, viruses that infect and destroy specific gut bacteria, he added.

Dr. Dishaw with some laboratory team members. From left: Michael Schepps, undergraduate research assistant; Zachary Graham, lab technician; and Julie Voelschow, undergraduate research assistant. Not pictured are Ojas Natarajan, PhD, postdoctoral scientist; and Celine Atkinson, graduate student.

“The goal of our project is to find out what happens when we muck with that system. When the VCBPs don’t bind fungi or bacteria correctly, how is the physiological fitness of the animal affected?” Dr. Dishaw said. “We believe these immune effectors can shape the ecology of the gut microbiome in ways that promote (or deter) health. And we think the sea squirt model can help us understand how that happens.”

The researchers can rear germ-free juvenile Ciona, then introduce into their water whatever microbes they choose. Because the sea squirt filters water constantly, they can quickly track where in this controlled environment the newly introduced gut microbe populations settle and thrive as well as examine the role host-microbe interactions play in developing a frontline immune defense system.

In a series of experiments published last year in Open Biology, the USF researchers induced colitis-like inflammation and damage in sea squirts by exposing their guts to the chemical dextran sulfate sodium (DSS). They showed that DSS altered the production and settlement of the secreted immune molecule that binds bacteria.

The laboratory grows its own algae, cultured in beakers shown on the windowsill, to feed to the juvenile sea squirts.

Most invertebrates, including sea squirts, defend their gut walls against potential microbial attack and prevent infection with mucous rich in chitin. The researchers found that pretreatment with microparticles of chitin, a fibrous substance prevalent in Ciona’s epithelium-associated gut mucous, protected the animal from the colitis-like effects of subsequent DSS exposure.

Ciona, which permits the study of innate immunity in isolation, “may help us determine how innate immunity modulates recovery from colitis and the re-establishment of (gut microbiome) homeostasis,” the study authors concluded.

Promising power of phages to treat drug-resistant infections

Dr. Dishaw is also co-investigator for a National Institutes of Health grant led by the USF College of Nursing’s Maureen Groer, PhD. The project is investigating the link between the gut microbiome of premature infants and their health as they age.

Lab tech Zachary Graham and Dr. Dishaw look over culture plates of bacterial biofilms stained with crystal violet. The bacteria were recovered from the gut of the sea squirts.

“We think early colonization of microbes is critically important in establishing lifelong gut microbiome features,” Dr. Dishaw said. “So, early life events that shape the (evolving) microbiome — like spending 4 to 6 weeks in a neonatal intensive care unit where the infant receives multiple antibiotics to treat or prevent infections — could translate into long-term changes in health.”

The ultimate goal of microbiome research is to come up with effective treatments to reset the equilibrium of a microbial community gone awry – whether by diet, stress, pathogens, or even the medications used to fight disease.

Fecal microbiota transplants, which insert a healthy donor’s fecal matter into a recipient’s colon to reconstitute a stable gut microbiome, have already become a relatively common treatment for Clostridium difficile (C. diff) infection, a debilitating gastrointestinal disease resistant to many antibiotics.

The crystal violet-stained cultures allow researchers to estimate the amount of biofilm formed during stationary growth of the bacteria.

In an age of growing multidrug resistance, Dr. Dishaw believes that phage therapy also offers promise as an alternative or supplement to antibiotics for patients suffering from recurrent, difficult-to-treat infections.  In another NSF grant with co-principal investigator Mya Breitbart of the USF College of Marine Sciences, he is colonizing a variety of bacteria in the sea squirts in an effort to test how phages – the viruses that infect bacteria – can be used to selectively eliminate harmful gut bacteria.

Phages, which specifically target single types of bacteria, might be harnessed to chase pathogens out of the microbial community without having to rely on antibiotics, which can wipe out both harmful and beneficial bacteria, Dr. Dishaw said. “In theory, you could use a C diff phage with high precision to target and kill only C. diff bacteria.”

Dr. Dishaw also participates in a clinical study with the USF Health Department of Pediatrics and Johns Hopkins All Children’s Hospital to characterize the gut microbiomes of patients with primary immune deficiencies.  The research may provide a better understanding of how different aspects of immunity regulate the gut microbiome.

Microscopic image of a juvenile sea squirt shows its gut colonized by fluorescently labeled bacteria

-Video and photos by Torie Doll, USF Health Communications and Marketing

Joann Farrell Quinn, PhD.

Imagine you’re the manager of an equity-trading desk and you see two employees constantly in conflict and arguing with each other. You don’t understand why and don’t see an end in sight.  What do you do?

Seeing scenarios like this play out when she was an equity trader prompted Joann Farrell Quinn, PhD, to earn her doctorate degree in organizational Behavior from Case Western University to help answer the question “What makes people tick?”

Dr. Quinn is the competency assessment director for the USF Health Morsani College of Medicine Scholarly Excellence, Leadership Experiences, Collaborative Training (SELECT) program. She and the SELECT team administer the Emotional Social Competency Inventory (ESCI) to SELECT students several times throughout medical school using a model that focuses on self-awareness, self-management, social awareness, and relationship management.  The ESCI uses those four focus areas to help students understand how to use their own emotional and social competency to communicate more effectively, a must for aspiring doctors.

“Emotional intelligence has always been important, but lately it’s been more of a topic of discussion given how [health care] organizations are set up to be more interprofessional with people moving between teams constantly,” Dr. Quinn said.

Emotional intelligence is simply about understanding what’s happening and finding ways to mitigate the effects of certain emotions, she said.  This is one of the first steps to preventing burnout in medical school and in the profession of medicine.

“Medical school is a big lifestyle change.  Students come into a new setting and must develop new processes for how they retain lecture content and study. If we can give them the tools ahead of time to recognize the signs that things are starting to slip, it’s like training your brain what to do before it happens,” she said.  “We can combat burnout by being self-aware. The more aware our medical students are, the better doctors they are likely to become.”

Dr. Quinn is a sub-award principal investigator for an $880,000 grant recently awarded to Rochester Institute of Technology professor Casey Miller from the National Science Foundation INCLUDES program, a national program that seeks to boost efforts to create a more diverse workforce in science, technology, engineering and mathematics (STEM). The parent award is an $8 million award, which is one of the NSF’s 10 Big Ideas for 2018.  Dr. Quinn is developing an assessment to gauge applicants’ behaviors related to emotional and social characteristics of successful PhD researchers, such as self-awareness, adaptability and grit.

“The short-term goal is to come up with a valid, reliable instrument that programs can use as part of their application process to assist in deciding which applicants they are going to accept into their PhD programs. Long term, I’d like to expand that into all professional degree programs,” she said.

With additional grant funding, she hopes to be able to focus her research to other professional degrees career paths including medical degrees, and Juris Doctorates, in addition to all PhD programs.

Photo by Fredrick J. Coleman, USF Health Communications and Marketing

The University of South Florida continues to rise in the national rankings for research, now ranked 25th among all public research universities nationwide in total research spending, according to the latest data released by the National Science Foundation (NSF).  The university ranked 27th last year.

In the category of medical sciences, USF topped the list in funds spent on research and development among all Florida public universities ranked by NSF — with $96.6 million in expenditures by USF Health and affiliate Moffitt Cancer Center.  Only the University of Miami, a private institution, ranked higher in medical research expenditures.

In the rankings for all universities, both public and private, USF moved to No. 41 nationally for total research expenditures, up two places from No. 43, where the university was ranked the previous two years, and is ranked No. 2 in Florida.

Read more…